1. Home
  2. MARA vs AMRX Comparison

MARA vs AMRX Comparison

Compare MARA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Digital Holdings Inc.

MARA

Marathon Digital Holdings Inc.

HOLD

Current Price

$13.80

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.44

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MARA
AMRX
Founded
2010
2002
Country
United States
United States
Employees
N/A
8500
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
MARA
AMRX
Price
$13.80
$12.44
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$17.85
$15.60
AVG Volume (30 Days)
38.4M
1.4M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
$907,093,000.00
N/A
Revenue This Year
N/A
$4.48
Revenue Next Year
$13.31
$7.13
P/E Ratio
N/A
$65.29
Revenue Growth
38.20
N/A
52 Week Low
$6.66
$7.07
52 Week High
$23.45
$15.42

Technical Indicators

Market Signals
Indicator
MARA
AMRX
Relative Strength Index (RSI) 65.17 46.41
Support Level $9.65 $11.60
Resistance Level $16.63 $12.85
Average True Range (ATR) 0.90 0.37
MACD 0.01 -0.06
Stochastic Oscillator 87.64 31.49

Price Performance

Historical Comparison
MARA
AMRX

About MARA Marathon Digital Holdings Inc.

MARA Holdings Inc leverages digital asset computing to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for Bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: